These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24526236)

  • 1. Pregnancies after transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension.
    Nicolas C; Ferrand E; d'Alteroche L; Ayoub J; Bastides F; Potin J; Perarnau JM
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):488-90. PubMed ID: 24526236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular Intrahepatic Portosystemic Shunt Placement During Pregnancy: A Case Series of Five Patients.
    Ingraham CR; Padia SA; Johnson GE; Easterling TR; Liou IW; Kanal KM; Valji K
    Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1205-10. PubMed ID: 25613670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in portal venous pressure by transjugular intrahepatic portosystemic shunt for treatment of hemorrhagic stomal varices.
    Deipolyi AR; Kalva SP; Oklu R; Walker TG; Wicky S; Ganguli S
    AJR Am J Roentgenol; 2014 Sep; 203(3):668-73. PubMed ID: 25148174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study.
    Lafortune M; Martinet JP; Denys A; Patriquin H; Dauzat M; Dufresne MP; Colombato L; Pomier-Layrargues G
    AJR Am J Roentgenol; 1995 Apr; 164(4):997-1002. PubMed ID: 7726065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome using the fluency stent graft for transjugular intrahepatic portosystemic shunt in patients with portal hypertension.
    Wu X; Ding W; Cao J; Fan X; Li J
    Am Surg; 2013 Mar; 79(3):305-12. PubMed ID: 23461959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent position of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension.
    Svoboda P; Kantorova I; Brhelova H; Vasickova J; Ochmann J
    Hepatogastroenterology; 1997; 44(15):647-55. PubMed ID: 9222665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transjugular intrahepatic portosystemic shunt (TIPS)].
    Peck-Radosavljevic M; Pidlich J
    Wien Klin Wochenschr; 2000 Nov; 112(22):947-54. PubMed ID: 11142132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The transjugular intrahepatic portosystemic stent-shunt (TIPS) in the management of portal hypertension. A preliminary report].
    Aguilar Ramírez JR; Alcantara Peraza RA; Hernández Pérez RE; Gómez Maganda y Silva T; Heredia Jarero NM; Torres Valadez F; Gómez del Campo López A
    Rev Gastroenterol Mex; 1994; 59(3):218-22. PubMed ID: 7716362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension.
    Bissonnette J; Garcia-Pagán JC; Albillos A; Turon F; Ferreira C; Tellez L; Nault JC; Carbonell N; Cervoni JP; Abdel Rehim M; Sibert A; Bouchard L; Perreault P; Trebicka J; Trottier-Tellier F; Rautou PE; Valla DC; Plessier A
    Hepatology; 2016 Jul; 64(1):224-31. PubMed ID: 26990687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of symptomatic portal hypertension].
    Krajina A; Hůlek P; Eliás P; Michl A; Zizka J; Nozicka J; Vanásek T; Lojík M; Niangová I; Volfová M; Pozler O; Erben J; Papík Z; Bures J
    Cas Lek Cesk; 1996 Sep; 135(18):584-8. PubMed ID: 8998798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular portosystemic shunt in chronic portal vein occlusion: importance of segmental portal hypertension in cavernous transformation of the portal vein.
    Walser EM; Soloway R; Raza SA; Gill A
    J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):373-8. PubMed ID: 16517786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
    Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparison of efficacies between transjugular intrahepatic portosystemic shunt versus portoazygos devascularization in the treatment of portal hypertension with variceal bleeding].
    Xu XB; Chu JG; Huang H; Zhang HY; Zhang HY; Liu CL; Xiao M; Zhang H; Feng ZQ; Zhao G
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2542-5. PubMed ID: 23158794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines?
    Riggio O; Ridola L; Lucidi C; Angeloni S
    Dig Liver Dis; 2010 Jul; 42(7):462-7. PubMed ID: 20036625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic encephalopathy as an unusual late complication of transjugular intrahepatic portosystemic shunt insertion for non-cirrhotic portal hypertension caused by nodular regenerative hyperplasia in an HIV-positive patient on highly active antiretroviral therapy.
    Ding A; Lee A; Callender M; Loughrey M; Quah SP; Dinsmore WW
    Int J STD AIDS; 2010 Jan; 21(1):71-2. PubMed ID: 20029067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and splanchnic perfusion and oxygenation after transjugular intrahepatic portosystemic shunt.
    Cervera M; Añón R; Palmero J; Martínez J; Garcés R; Ripollés T; Moreno-Osset E; Alamán G; Antón M
    Rev Esp Enferm Dig; 2000 Apr; 92(4):199-210. PubMed ID: 10867409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.